Stay updated on BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.2 and removed Rheumatoid arthritis, related topics: MedlinePlus Genetics and Revision: v3.2.0.SummaryDifference0.2%

- Check19 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics; removed the government funding status notice.SummaryDifference0.4%

- Check26 days agoChange DetectedThe deletions remove the terms 'Rheumatoid arthritis' and 'MedlinePlus Genetics' from the page's related topics/keywords. The main study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page removed the related topics 'Rheumatoid arthritis' and the related topic 'MedlinePlus Genetics' from the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded MedlinePlus Genetics topic on Rheumatoid arthritis to the page, strengthening coverage of genetic aspects of a specific autoimmune condition.SummaryDifference0.2%

Stay in the know with updates to BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial page.